Home
About Us
Structure
Current Events
Past Events
Policy & Reports
Awards
Membership
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

   
13th Annual BioPharma & Healthcare Summit, Thursday, May 9, 2019
Registration is closed
The Summit has reached full capacity. Registration is closed. There is no onsite registration.
Thanks for your overwhelming response. See you at 2020 summit!

Chair and Master of Ceremonies (Emcee)– Dr. Andrew Plump, President of R&D, Takeda Pharmaceuticals

13th annual BioPharma & Healthcare Summit
Date: Thursday, May 9, 2019
Time: 8-45 AM to 6-15 PM
Location: Grand Ballroom, Marriott Cambridge, Kendall Square, Massachusetts, USA 

 

Time Topic
8:40 AM - 9:10 AM Registration and Networking
9:10 AM - 9:20 AM Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr Andrew Plump, President R&D and Director, Takeda Pharmaceuticals
9:20 AM - 9:40 AM

Fireside Chat

  • Mark Abdoo, Acting Deputy Commissioner, U.S. Food and Drug Administration
  • Dr Eswara Reddy, Drug Controller General of India, Central Drug Control Organization

Moderator: Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.

9:40 AM - 10:00 AM Presentation on CAR (chimeric antigen receptor) T-cell Therapies
Dr. Carl June, Director of Translational Research, Abramson Cancer Center University of Pennsylvania

Moderator: Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School
10:00 AM - 10:50 AM Panel Discussion: Oncology – The Emperor of BioPharma Development

Panelists: Moderator: Dr. Christiana Bardon, Managing Director, MPM Capital
10:50 AM - 11:20 AM Networking Break
11:20 AM - 12:10 PM Panel Discussion: Future of Clinical Trials and Drug Development

Panelists: Moderator: Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
12:10 PM - 1:00 PM Panel Discussion: Manufacturing in the Future

Panelists:
  • Hari Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group
  • Mark Abdoo, Acting Deputy Commissioner, U.S. Food and Drug Administration
  • Dr. Paul McKenzie, Executive Vice President, Pharma Operations & Technology, Biogen
  • Sanat Chattopadhyay, President, Merck Manufacturing Division; Merck & Co.
  • Vinay Ranade, Chief Executive Officer, Reliance Life Sciences
Moderator: Professor N. Venkat Venkatraman, Boston University Questrom School of Business
1:00 PM - 1:50 PM Lunch
1:50 PM - 1:55 PM Video message from Suresh Prabhu, Hon'ble Minister of Commerce & Industry, Gov. of India
1:55 PM - 2:45 PM Panel Discussion: One in a million - Emerging trends in Rare Diseases

Panelists:
Moderator: Dr. Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics
2:45 PM - 3:20 PM Networking & Tea Break
3:20 PM - 3:50 PM Fireside Chat: Value and Access – The ongoing debate Moderator: Dr Andrew Plump, President R&D, Takeda Pharmaceuticals
3:50 PM - 4:10 PM

India update on Clinical Trial Regulations

  • Arun Singhal, Additional Secretary, Ministry of Health & Family Welfare, India
  • Dr Eswara Reddy, Drug Controller General of India, Central Drug Control Organization
4:10 PM - 5:00 PM Panel Discussion: Research and Development Strategies and Trends

Panelists: Moderator: Dr. Martin Mackay, Co-Founde, Rallybio
5:00 PM - 5:05 PM Closing Remarks
5:05 PM - 6:15 PM Cocktails & Networking Reception

*Lunch will be served at the table at 1 PM. Panel will start at 1:50 PM
*Speaker and Timings subject to change      

 
Please keep your cell phones in the silent mode

Pharmasia News   Biospectrum India Online
 



















© 2007 - USA India Chamber of Commerce Home | About us | Agenda | | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Internship/Volunteers | Legal | Contact us